Dr. Connie Lehman on how Clairity predicts breast cancer
Dr. Connie Lehman has spent her career looking at mammograms differently. A Harvard Medical School professor and Yale-trained …
A Closer Look at the Latest Updates to the NCCN Guidelines on Breast Cancer Screening
In a recent interview, Connie Lehman, MD, PhD, discussed key changes to the National Comprehensive Cancer Network (NCCN) guidelines on …
The Risk Revolution: AI’s Role in Breast Cancer Risk, Prevention and Diagnosis
A seismic shift is happening in how we understand and manage breast cancer risk. For decades, mammography was used primarily to detect …
CLAIRITY BREAST: First A.I. Tool Authorized by FDA to Predict 5-year Breast Cancer Risk.
Breast cancer kills 42,000+ women in the USA annually. Connie Lehman, MD, PhD & Jeff Luber, JD, MBA of CLAIRITY, Inc. have received FDA …
How an AI Scientist Turned Her Breast Cancer Diagnosis Into a Tool to Save Lives
The development of an AI-based system for early detection of breast cancer has the ability to predict whether a patient is likely to …